Top Markets
Coin of the day
Alpine Immune Sciences, Inc. Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc.

ALPN
Classificação em ações #6581
Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company... Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company focused on discovering and advancing protein-based immunotherapies. Their therapeutic endeavors address a range of conditions, including various cancers, autoimmune and inflammatory disorders, among others. The company's pipeline features ALPN-101, an ICOS/CD28 antagonist program being developed for autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor aimed at treating cancer; and ALPN-303, a dual B cell cytokine antagonist for B cell-mediated inflammatory and autoimmune conditions. Alpine Immune Sciences has established strategic collaborations, including an agreement with AbbVie Ireland Unlimited Company for the development of ALPN-101, and a partnership with Adaptimmune Therapeutics plc to create next-generation SPEAR T cell products. The company was founded in 2007 and operates from its headquarters in Seattle, Washington.
Preço da ação
$64.97
Última sincronização: 2024-05-20
Valor de mercado
$1.97B
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Alpine Immune Sciences, Inc. (ALPN)

Categoria

Histórico de desdobramentos de ações de Alpine Immune Sciences, Inc. (ALPN)
As ações Alpine Immune Sciences, Inc. (símbolo: ALPN) passaram por um total de 1 desdobramentos.
O desdobramento mais recente ocorreu em Jul 25, 2017.
Uma ação ALPN comprada antes de Jul 25, 2017 equivaleria hoje a 0.25 ações ALPN.
Lista de desdobramentos de ações
Ano Desdobramento Multiplicador Multiplicador cumulativo
2017-07-25 1:4 x0.25 x0.25
Desdobramentos de ações de empresas semelhantes ou concorrentes
Empresa Número de desdobramentos de ações Multiplicador cumulativo País
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH